EUVIMEDEUVIMED entdecken
Open Access

Programmable multistep CRISPR gene activation via control of RNA polymerase III termination

Anupama K Puppala iD, Andrew C Nielsen iD, Maureen Regan, Georgina E Mancinelli iD, Renee F De Pooter, Stephen Arnovitz iD, Caspian Harding iD, Michaele McGregor iD, Nikolas G Balanis, Ryan Clarke iD, Bradley J Merrill iD

Science Advances · 2025

DOI: 10.1126/sciadv.adt1532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Anupama K Puppala und 10 weiteren Autor:innen. Beteiligte Einrichtung: Syntax Bio Inc., Chicago, IL 60642, USA. Hauptthemen laut MEDLINE: RNA Polymerase III, CRISPR-Cas Systems, Transcriptional Activation, Clustered Regularly Interspaced Short Palindromic Repeats. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although genomes encode instructions for mammalian cell differentiation with rich syntactic relationships, existing methods for genetically programming cells have only modest capabilities for stepwise gene regulation. Here, we develop a sequential genetic system that transcriptionally activates endogenous genes in a preprogrammed, stepwise manner. This system uses the removal of an RNA polymerase III termination sequence to trigger both the transcriptional activation and DNA endonuclease activities of a Cas9-VPR protein, driving progression through a cascade of gene activation events. The system’s functionality in human cells, including iPSCs, enables the development of a path for cellular programming by controlling the sequential order of gene activation to influence cellular states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Polymerase IIICRISPR-Cas SystemsTranscriptional ActivationClustered Regularly Interspaced Short Palindromic RepeatsHumansGene EditingInduced Pluripotent Stem CellsHEK293 Cells

Substanzen

RNA Polymerase III

Autor:innen und Institutionen

  • Syntax Bio Inc., Chicago, IL 60642, USA.
  • Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL 60607, USA.

ORCID-Profile: Anupama K Puppala, Andrew C Nielsen, Georgina E Mancinelli, Stephen Arnovitz, Caspian Harding, Michaele McGregor, Ryan Clarke, Bradley J Merrill

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Puppala, A. K., Nielsen, A. C., Regan, M., Mancinelli, G. E., De Pooter, R. F., Arnovitz, S., Harding, C., McGregor, M., Balanis, N. G., Clarke, R., & Merrill, B. J. (2025). Programmable multistep CRISPR gene activation via control of RNA polymerase III termination. Science Advances. https://doi.org/10.1126/sciadv.adt1532

Vancouver

Puppala AK, Nielsen AC, Regan M, Mancinelli GE, De Pooter RF, Arnovitz S, et al. Programmable multistep CRISPR gene activation via control of RNA polymerase III termination. Science Advances. 2025. doi:10.1126/sciadv.adt1532

BibTeX
@article{Puppala2025,
  author = {Puppala, Anupama K and Nielsen, Andrew C and Regan, Maureen and Mancinelli, Georgina E and De Pooter, Renee F and Arnovitz, Stephen and Harding, Caspian and McGregor, Michaele and Balanis, Nikolas G and Clarke, Ryan and Merrill, Bradley J},
  title = {Programmable multistep CRISPR gene activation via control of RNA polymerase III termination},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adt1532}
}
Kostenlos starten →